Ligands of Immunopharmacology

Emlenoflast (MCC7840) sodium, a sulfonylurea, is a potent and selective inhibitor of NLRP3 inflammasome , with an IC 50 of &lt100 nM. Emlenoflast sodium can be used for the research of inflammatory diseasesIn VitroEmlenoflast, a MCC950 analogue,

Emlenoflast (MCC7840) sodium, a sulfonylurea, is a potent and selective inhibitor of NLRP3 inflammasome , with an IC 50 of &lt100 nM. Emlenoflast sodium can be used for the research of inflammatory diseasesIn VitroEmlenoflast, a MCC950 analogue,

Emlenoflast (MCC7840) sodium, a sulfonylurea, is a potent and selective inhibitor of NLRP3 inflammasome , with an IC 50 of &lt100 nM. Emlenoflast sodium can be used for the research of inflammatory diseasesIn VitroEmlenoflast, a MCC950 analogue,

Enpatoran (M5049) hydrochloride is a potent, orally active and dual TLR7/8 inhibitor with IC 50 s of 11.1 nM and 24.1 nM in HEK293 cells, respectively. Enpatoran hydrochloride is inactive against TLR3 , TLR4 and TLR9 . Enpatoran hydrochloride can

Enpatoran (M5049) hydrochloride is a potent, orally active and dual TLR7/8 inhibitor with IC 50 s of 11.1 nM and 24.1 nM in HEK293 cells, respectively. Enpatoran hydrochloride is inactive against TLR3 , TLR4 and TLR9 . Enpatoran hydrochloride can

Enpatoran (M5049) hydrochloride is a potent, orally active and dual TLR7/8 inhibitor with IC 50 s of 11.1 nM and 24.1 nM in HEK293 cells, respectively. Enpatoran hydrochloride is inactive against TLR3 , TLR4 and TLR9 . Enpatoran hydrochloride can

Enpatoran (M5049) hydrochloride is a potent, orally active and dual TLR7/8 inhibitor with IC 50 s of 11.1 nM and 24.1 nM in HEK293 cells, respectively. Enpatoran hydrochloride is inactive against TLR3 , TLR4 and TLR9 . Enpatoran hydrochloride can

FAP-2286, a fibroblast activation protein (FAP) -binding peptidic macrocycle coupled to the radionuclide chelator DOTA. FAP-2286 has potent affinity to human FAP protein with a K d of 1.1 nM. FAP-2286, a tumor imaging agent, is a useful tool for the

FAPI-34 is a fibroblast-activating protein (FAP) inhibitor with favorable pharmacokinetic and biochemical properties. (patent WO2019154886A1).Form:SolidIC50&amp Target:Fibroblast activation protein (FAP)

FAPI-4 is a potent fibroblast activation protein ( FAP ) inhibitor for the targeting FAP. FAPI-4 can be used in cancer research. 68 Ga-FAPI-4 PET/CT is a promising new diagnostic method for imaging various kinds of cancer , with good

FAPI-4 is a potent fibroblast activation protein ( FAP ) inhibitor for the targeting FAP. FAPI-4 can be used in cancer research. 68 Ga-FAPI-4 PET/CT is a promising new diagnostic method for imaging various kinds of cancer , with good

FAPI-4 is a potent fibroblast activation protein ( FAP ) inhibitor for the targeting FAP. FAPI-4 can be used in cancer research. 68 Ga-FAPI-4 PET/CT is a promising new diagnostic method for imaging various kinds of cancer , with good